Nocturia as a manifestation of systemic disease

BJU International

Volumn 107, Issue 5, 2011, Pages 702-713

  Gulur, Dev Mohan ^a   Mevcha, Amit M ^a   Drake, Marcus J ^a  

^a SOUTHMEAD HOSPITAL   (United Kingdom)

Author keywords

lower urinary tract symptoms; nocturia; nocturnal polyuria; polyuria

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ARGIPRESSIN; ATRIAL NATRIURETIC FACTOR; CALCIUM CHANNEL BLOCKING AGENT; CELECOXIB; DESMOPRESSIN; DIURETIC AGENT; LITHIUM; MELATONIN; MUSCARINIC RECEPTOR BLOCKING AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; SEDATIVE AGENT; SEROTONIN UPTAKE INHIBITOR; STEROID 5ALPHA REDUCTASE INHIBITOR; TETRACYCLINE;

AGE DISTRIBUTION; AROUSAL; BLADDER CAPACITY; CIRCADIAN RHYTHM; CLINICAL ASSESSMENT; CLINICAL FEATURE; DISEASE ASSOCIATION; DRUG SAFETY; ETHNICITY; EXTRACELLULAR FLUID; FLUID BALANCE; FLUID INTAKE; GLOMERULUS FILTRATION; HUMAN; HYPONATREMIA; KIDNEY TUBULE ABSORPTION; KIDNEY TUBULE DISORDER; MICTURITION; NEPHROGENIC DIABETES INSIPIDUS; NOCTURIA; OBESITY; OVERACTIVE BLADDER; PARKINSON DISEASE; PATHOGENESIS; POLYURIA; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SENSORY NERVE; SEX DIFFERENCE; SLEEP APNEA SYNDROME; SLEEP DISORDER; SYSTEMIC DISEASE; TRANSURETHRAL RESECTION; URETHRA; URINARY FREQUENCY; URINE VOLUME;

ADULT; AGED; AGED, 80 AND OVER; CIRCADIAN RHYTHM; FEMALE; HUMANS; MALE; MIDDLE AGED; NOCTURIA; POLYURIA; QUALITY OF LIFE; URINARY BLADDER; URODYNAMICS;

EID: 79952267105     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2010.09763.x     Document Type: Review

References (108)

1. Abrams P, Cardozo L, Fall M, et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 2002; 21: 167-78 (Pubitemid 34195211)
2. Van Kerrebroeck P, Abrams P, Chaikin D, et al. The standardization of terminology in nocturia: report from the standardization subcommittee of the International Continence Society. BJU Int 2002; 90 (Suppl. 3): 11-5
3. Asplund R, Sundberg B, Bengtsson P,. Desmopressin for the treatment of nocturnal polyuria in the elderly: a dose titration study. Br J Urol 1998; 82: 642-6 (Pubitemid 28497746)
4. Homma Y, Yamaguchi O, Kageyama S, Nishizawa O, Yoshida M, Kawabe K,. Nocturia in the adult: classification on the basis of largest voided volume and nocturnal urine production. J Urol 2000; 163: 777-81 (Pubitemid 30091614)
5. Bing MH, Moller LA, Jennum P, Mortensen S, Skovgaard LT, Lose G,. Prevalence and bother of nocturia, and causes of sleep interruption in a Danish population of men and women aged 60-80 years. BJU Int 2006; 98: 599-604 (Pubitemid 44185884)
6. Fitzgerald MP, Litman HJ, Link CL, McKinlay JB,. The association of nocturia with cardiac disease, diabetes, body mass index, age and diuretic use: results from the BACH survey. J Urol 2007; 177: 1385-9 (Pubitemid 46436009)
7. Weiss JP, Blaivas JG, Jones M, Wang JT, Guan Z,. Age related pathogenesis of nocturia in patients with overactive bladder. J Urol 2007; 178: 548-51 (Pubitemid 47030497)
8. Fiske J, Scarpero HM, Xue X, Nitti VW,. Degree of bother caused by nocturia in women. Neurourol Urodyn 2004; 23: 130-3 (Pubitemid 38296199)
9. Yu HJ, Chen FY, Huang PC, Chen TH, Chie WC, Liu CY,. Impact of nocturia on symptom-specific quality of life among community-dwelling adults aged 40 years and older. Urology 2006; 67: 713-8
10. Asplund R, Johansson S, Henriksson S, Isacsson G,. Nocturia, depression and antidepressant medication. BJU Int 2005; 95: 820-3 (Pubitemid 40547214)
11. Kobelt G, Borgstrom F, Mattiasson A,. Productivity, vitality and utility in a group of healthy professionally active individuals with nocturia. BJU Int 2003; 91: 190-5 (Pubitemid 36232833)
12. van Dijk L, Kooij DG, Schellevis FG,. Nocturia in the Dutch adult population. BJU Int 2002; 90: 644-8 (Pubitemid 35356626)
13. Asplund R,. Hip fractures, nocturia, and nocturnal polyuria in the elderly. Arch Gerontol Geriatr 2006; 43: 319-26 (Pubitemid 44634127)
14. Milsom I, Abrams P, Cardozo L, Roberts RG, Thüroff J, Wein AJ,. How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study. BJU Int 2001; 87: 760-6 (Pubitemid 34204313)
15. Jennum P,. Sleep and nocturia. BJU Int 2002; 90 (Suppl. 3): 21-4 (Pubitemid 35422702)
16. Crenshaw MC, Edinger JD,. Slow-wave sleep and waking cognitive performance among older adults with and without insomnia complaints. Physiol Behav 1999; 66: 485-92 (Pubitemid 29219444)
17. De Guchtenaere A, Vande Walle C, Van Sintjan P, et al. Nocturnal polyuria is related to absent circadian rhythm of glomerular filtration rate. J Urol 2007; 178: 2626-9 (Pubitemid 350052172)
18. Chang SC, Lin AT, Chen KK, Chang LS,. Multifactorial nature of male nocturia. Urology 2006; 67: 541-4 (Pubitemid 43343538)
19. Kanbay M, Turgut F, Uyar ME, Akcay A, Covic A,. Causes and mechanisms of nondipping hypertension. Clin Exp Hypertens 2008; 30: 585-97
20. Burnier M, Coltamai L, Maillard M, Bochud M,. Renal sodium handling and nighttime blood pressure. Semin Nephrol 2007; 27: 565-71 (Pubitemid 47374906)
21. Agarwal R, Light RP, Bills JE, Hummel LA,. Nocturia, nocturnal activity, nondipping. Hypertension 2009; 54: 646-51
22. Cheng CY, Chu JY, Chow BK,. Vasopressin-independent mechanisms in controlling water homeostasis. J Mol Endocrinol 2009; 43: 81-92
23. Chu JY, Lee LT, Lai CH, et al. Secretin as a neurohypophysial factor regulating body water homeostasis. Proc Natl Acad Sci USA 2009; 106: 15961-6
24. Zahariou A, Karamouti M, Karagiannis G, Papaioannou P,. Maximal bladder capacity is a positive predictor of response to desmopressin treatment in patients with MS and nocturia. Int Urol Nephrol 2008; 40: 65-9 (Pubitemid 351459872)
25. Pfisterer MH, Griffiths DJ, Rosenberg L, Schaefer W, Resnick NM,. The impact of detrusor overactivity on bladder function in younger and older women. J Urol 2006; 175: 1777-83
26. Hirayama A, Fujimoto K, Matsumoto Y, Hirao Y,. Nocturia in men with lower urinary tract symptoms is associated with both nocturnal polyuria and detrusor overactivity with positive response to ice water test. Urology 2005; 65: 1064-9 (Pubitemid 40824889)
27. Al-Hayek S, Belal M, Abrams P,. Does the patient's position influence the detection of detrusor overactivity? Neurourol Urodyn 2008; 27: 279-86 (Pubitemid 351656396)
28. Yeung CK, Sit FK, To LK, et al. Reduction in nocturnal functional bladder capacity is a common factor in the pathogenesis of refractory nocturnal enuresis. BJU Int 2002; 90: 302-7 (Pubitemid 34989080)
29. Cho SY, Yi JS, Oh SJ,. The clinical significance of poor bladder compliance. Neurourol Urodyn 2009; 28: 1010-4
30. Wyndaele JJ, De Wachter S,. Cystometrical sensory data from a normal population: comparison of two groups of young healthy volunteers examined with 5 years interval. Eur Urol 2002; 42: 34-8 (Pubitemid 35339642)
31. Drake MJ, Fowler CJ, Griffiths D, Mayer E, Paton JF, Birder L,. Neural control of the lower urinary and gastrointestinal tracts: supraspinal CNS mechanisms. Neurourol Urodyn 2010; 29: 119-27
32. Barrett TG, Bundey SE, Macleod AF,. Neurodegeneration and diabetes: UK nationwide study of Wolfram (DIDMOAD) syndrome. Lancet 1995; 346: 1458-63
33. Grunfeld JP, Rossier BC,. Lithium nephrotoxicity revisited. Nat Rev Nephrol 2009; 5: 270-6
34. Bettencourt P,. Brain natriuretic peptide (nesiritide) in the treatment of heart failure. Cardiovasc Drug Rev 2002; 20: 27-36 (Pubitemid 34651321)
35. Kasama S, Toyama T, Kumakura H, et al. Effects of intravenous atrial natriuretic peptide on cardiac sympathetic nerve activity in patients with decompensated congestive heart failure. J Nucl Med 2004; 45: 1108-13 (Pubitemid 47611655)
36. Torimoto K, Hirayama A, Samma S, Yoshida K, Fujimoto K, Hirao Y,. The relationship between nocturnal polyuria and the distribution of body fluid: assessment by bioelectric impedance analysis. J Urol 2009; 181: 219-24
37. Kaye M,. Aging, circadian weight change, and nocturia. Nephron Physiol 2008; 109: 11-8
38. Barion A, Zee PC,. A clinical approach to circadian rhythm sleep disorders. Sleep Med 2007; 8: 566-77 (Pubitemid 47181209)
39. Asplund R, Aberg H,. Diurnal variation in the levels of antidiuretic hormone in the elderly. J Intern Med 1991; 229: 131-4
40. Graugaard-Jensen C, Rittig S, Djurhuus JC,. Nocturia and circadian blood pressure profile in healthy elderly male volunteers. J Urol 2006; 176: 1034-9 (Pubitemid 44142602)
41. Ozawa T, Oyanagi K, Tanaka H, et al. Suprachiasmatic nucleus in a patient with multiple system atrophy with abnormal circadian rhythm of arginine-vasopressin secretion into plasma. J Neurol Sci 1998; 154: 116-21 (Pubitemid 28123226)
42. Yalkut D, Lee LY, Grider J, Jorgensen M, Jackson B, Ott C,. Mechanism of atrial natriuretic peptide release with increased inspiratory resistance. J Lab Clin Med 1996; 128: 322-8 (Pubitemid 27506944)
43. Romero E, Krakow B, Haynes P, Ulibarri V,. Nocturia and snoring: predictive symptoms for obstructive sleep apnea. Sleep Breath 2009; [Epub ahead of print]. DOI: 10.1007/s11325-009-0310-2
44. Endeshaw YW, Johnson TM, Kutner MH, Ouslander JG, Bliwise DL,. Sleep-disordered breathing and nocturia in older adults. J Am Geriatr Soc 2004; 52: 957-60 (Pubitemid 38789067)
45. Fitzgerald MP, Mulligan M, Parthasarathy S,. Nocturic frequency is related to severity of obstructive sleep apnea, improves with continuous positive airways treatment. Am J Obstet Gynecol 2006; 194: 1399-403
46. Hanly P,. Sleep disorders and end-stage renal disease. Curr Opin Pulm Med 2008; 14: 543-50
47. Robertson GL, Norgaard JP,. Renal regulation of urine volume: potential implications for nocturia. BJU Int 2002; 90 (Suppl. 3): 7-10 (Pubitemid 35417388)
48. Krol E, Rutkowski B, Czarniak P, et al. Early detection of chronic kidney disease: results of the PolNef study. Am J Nephrol 2009; 29: 264-73
49. Hsu CY, Iribarren C, McCulloch CE, Darbinian J, Go AS,. Risk factors for end-stage renal disease: 25-year follow-up. Arch Intern Med 2009; 169: 342-50
50. Gourova LW, van de Beek C, Spigt MG, Nieman FH, van Kerrebroeck PE,. Predictive factors for nocturia in elderly men: a cross-sectional study in 21 general practices. BJU Int 2006; 97: 528-32
51. Irwin DE, Abrams P, Milsom I, Kopp Z, Reilly K,. Understanding the elements of overactive bladder: questions raised by the EPIC study. BJU Int 2008; 101: 1381-7 (Pubitemid 351623987)
52. Hanno PM,. Diagnosis of interstitial cystitis. Urol Clin North Am 1994; 21: 63-6 (Pubitemid 24032768)
53. Petros PE, Woodman PJ,. The Integral Theory of continence. Int Urogynecol J Pelvic Floor Dysfunct 2008; 19: 35-40 (Pubitemid 350193852)
54. Youngstedt SD, Kripke DF, Elliott JA, Klauber MR,. Circadian abnormalities in older adults. J Pineal Res 2001; 31: 264-72 (Pubitemid 32905237)
55. Hakkinen JT, Shiri R, Koskimaki J, Tammela TL, Auvinen A, Hakama M,. Depressive symptoms increase the incidence of nocturia: Tampere Aging Male Urologic Study (TAMUS). J Urol 2008; 179: 1897-901
56. Tikkinen KA, Auvinen A, Huhtala H, Tammela TL,. Nocturia and obesity: a population-based study in Finland. Am J Epidemiol 2006; 163: 1003-11 (Pubitemid 43987592)
57. Kim HJ, Park SY, Cho YJ, et al. Nonmotor symptoms in de novo Parkinson disease before and after dopaminergic treatment. J Neurol Sci 2009; 287: 200-4
58. Sammour ZM, Gomes CM, Barbosa ER, et al. Voiding dysfunction in patients with Parkinson's disease: impact of neurological impairment and clinical parameters. Neurourol Urodyn 2009; 28: 510-5
59. Tibaek S, Gard G, Klarskov P, Iversen HK, Dehlendorff C, Jensen R,. Prevalence of lower urinary tract symptoms (LUTS) in stroke patients: a cross-sectional, clinical survey. Neurourol Urodyn 2008; 27: 763-71
60. Shiri R, Hakama M, Hakkinen J, et al. The effects of lifestyle factors on the incidence of nocturia. J Urol 2008; 180: 2059-62
61. Kupelian V, McVary KT, Kaplan SA, et al. Association of lower urinary tract symptoms and the metabolic syndrome: results from the Boston Area Community Health Survey. J Urol 2009; 182: 616-25
62. Kupelian V, Shabsigh R, Araujo AB, O'Donnell AB, McKinlay JB,. Erectile dysfunction as a predictor of the metabolic syndrome in aging men: results from the Massachusetts Male Aging Study. J Urol 2006; 176: 222-6 (Pubitemid 43815376)
63. Abrams P, Avery K, Gardener N, Donovan J,. The international consultation on incontinence modular questionnaire:. J Urol 2006; 175: 1063-6 (Pubitemid 43200089)
64. Devine EB, Hakim Z, Green J,. A systematic review of patient-reported outcome instruments measuring sleep dysfunction in adults. Pharmacoeconomics 2005; 23: 889-912 (Pubitemid 41317424)
65. Matthiesen TB, Rittig S, Mortensen JT, Djurhuus JC,. Nocturia and polyuria in men referred with lower urinary tract symptoms, assessed using a 7-day frequency-volume chart. BJU Int 1999; 83: 1017-22 (Pubitemid 29271872)
66. Weiss JP, Blaivas JG, Stember DS, Chaikin DC,. Evaluation of the etiology of nocturia in men: the nocturia and nocturnal bladder capacity indices. Neurourol Urodyn 1999; 18: 559-65 (Pubitemid 29522184)
67. Fujikawa K, Kasahara M, Matsui Y, Takeuchi H,. Human atrial natriuretic peptide is a useful criterion in treatment of nocturia. Scand J Urol Nephrol 2001; 35: 310-3 (Pubitemid 32906854)
68. Brubaker L, FitzGerald MP,. Nocturnal polyuria and nocturia relief in patients treated with solifenacin for overactive bladder symptoms. Int Urogynecol J Pelvic Floor Dysfunct 2007; 18: 737-41 (Pubitemid 47023322)
69. Yap TL, Brown C, Cromwell DA, van der Meulen J, Emberton M,. The impact of self-management of lower urinary tract symptoms on frequency-volume chart measures. BJU Int 2009; 104: 1104-8
70. McCrae CS,. Late-life comorbid insomnia: diagnosis and treatment. Am J Manag Care 2009; 15 (Suppl.): S14-23
71. Foley D, Ancoli-Israel S, Britz P, Walsh J,. Sleep disturbances and chronic disease in older adults: results of the 2003 National Sleep Foundation Sleep in America Survey. J Psychosom Res 2004; 56: 497-502 (Pubitemid 38686688)
72. Reynard J,. Fluid balance therapy of nocturia in women. Int Urogynecol J Pelvic Floor Dysfunct 1999; 10: 43-8 (Pubitemid 29132256)
73. Griffiths DJ, McCracken PN, Harrison GM, Gormley EA,. Relationship of fluid intake to voluntary micturition and urinary incontinence in geriatric patients. Neurourol Urodyn 1993; 12: 1-7 (Pubitemid 23028852)
74. Asplund R, Aberg H,. Health of the elderly with regard to sleep and nocturnal micturition. Scand J Prim Health Care 1992; 10: 98-104
75. Schneider T, de la Rosette JJ, Michel MC,. Nocturia: a non-specific but important symptom of urological disease. Int J Urol 2009; 16: 249-56
76. Kojima T, Akishita M, Iijima K, Eto M, Ouchi Y,. Nocturia in elderly people with hypertension-no influence of low-dose thiazide added to losartan. J Am Geriatr Soc 2008; 56: 2155-6
77. Vaughan CP, Endeshaw Y, Nagamia Z, Ouslander JG, Johnson TM,. A multicomponent behavioural and drug intervention for nocturia in elderly men: rationale and pilot results. BJU Int 2009; 104: 69-74
78. Reynard J,. A novel therapy for nocturnal polyuria: a double-blind randomized trial of frusemide against placebo. Br J Urol 1998; 82: 932 (Pubitemid 28556759)
79. Williams G, Donaldson R,. A novel therapy for nocturnal polyuria: a double-blind randomized trial of frusemide against placebo. Br J Urol 1998; 82: 165-6 (Pubitemid 28316696)
80. Cho MC, Ku JH, Paick JS,. Alpha-blocker plus diuretic combination therapy as second-line treatment for nocturia in men with LUTS: a pilot study. Urology 2009; 73: 549-55
81. Lose G, Lalos O, Freeman RM, van Kerrebroeck P,. Efficacy of desmopressin (Minirin) in the treatment of nocturia: a double-blind placebo-controlled study in women. Am J Obstet Gynecol 2003; 189: 1106-13 (Pubitemid 37373906)
82. Mattiasson A, Abrams P, Van Kerrebroeck P, Walter S, Weiss J,. Efficacy of desmopressin in the treatment of nocturia: a double-blind placebo-controlled study in men. BJU Int 2002; 89: 855-62 (Pubitemid 34535416)
83. van Kerrebroeck P, Rezapour M, Cortesse A, Thuroff J, Riis A, Norgaard JP,. Desmopressin in the treatment of nocturia: a double-blind, placebo-controlled study. Eur Urol 2007; 52: 221-9 (Pubitemid 46803012)
84. Weatherall M,. The risk of hyponatremia in older adults using desmopressin for nocturia: a systematic review and meta-analysis. Neurourol Urodyn 2004; 23: 302-5 (Pubitemid 38859418)
85. Rembratt A, Riis A, Norgaard JP,. Desmopressin treatment in nocturia; an analysis of risk factors for hyponatremia. Neurourol Urodyn 2006; 25: 105-9
86. Bae JH, Oh MM, Shim KS, et al. The effects of long-term administration of oral desmopressin on the baseline secretion of antidiuretic hormone and serum sodium concentration for the treatment of nocturia: a circadian study. J Urol 2007; 178: 200-3 (Pubitemid 46898486)
87. Garfinkel D, Laudon M, Nof D, Zisapel N,. Improvement of sleep quality in elderly people by controlled-release melatonin. Lancet 1995; 346: 541-4
88. Sugaya K, Nishijima S, Miyazato M, Kadekawa K, Ogawa Y,. Effects of melatonin and rilmazafone on nocturia in the elderly. J Int Med Res 2007; 35: 685-91 (Pubitemid 47570489)
89. Drake MJ, Mills IW, Noble JG,. Melatonin pharmacotherapy for nocturia in men with benign prostatic enlargement. J Urol 2004; 171: 1199-202 (Pubitemid 38327558)
90. Saito M, Kawatani M, Kinoshita Y, Satoh K, Miyagawa I,. Effectiveness of an anti-inflammatory drug, loxoprofen, for patients with nocturia. Int J Urol 2005; 12: 779-82 (Pubitemid 41743367)
91. Araki T, Yokoyama T, Araki M, Furuya S,. A clinical investigation of the mechanism of loxoprofen, a non-steroidal anti-inflammatory drug, for patients with nocturia. Acta Med Okayama 2008; 62: 373-8
92. Brubaker L, Cundiff GW, Fine P, et al. Abdominal sacrocolpopexy with Burch colposuspension to reduce urinary stress incontinence. N Engl J Med 2006; 354: 1557-66
93. Chapple CR, Cardozo L, Steers WD, Govier FE,. Solifenacin significantly improves all symptoms of overactive bladder syndrome. Int J Clin Pract 2006; 60: 959-66 (Pubitemid 44082287)
94. Nitti VW, Dmochowski R, Appell RA, Wang JT, Bavendam T, Guan Z,. Efficacy and tolerability of tolterodine extended-release in continent patients with overactive bladder and nocturia. BJU Int 2006; 97: 1262-6 (Pubitemid 43907334)
95. Rackley R, Weiss JP, Rovner ES, Wang JT, Guan Z,. Nighttime dosing with tolterodine reduces overactive bladder-related nocturnal micturitions in patients with overactive bladder and nocturia. Urology 2006; 67: 731-6
96. Kaplan SA, Roehrborn CG, Dmochowski R, Rovner ES, Wang JT, Guan Z,. Tolterodine extended release improves overactive bladder symptoms in men with overactive bladder and nocturia. Urology 2006; 68: 328-32 (Pubitemid 44175507)
97. Paick JS, Ku JH, Shin JW, Yang JH, Kim SW,. Alpha-blocker monotherapy in the treatment of nocturia in men with lower urinary tract symptoms: a prospective study of response prediction. BJU Int 2006; 97: 1017-23
98. Koseoglu H, Aslan G, Ozdemir I, Esen A,. Nocturnal polyuria in patients with lower urinary tract symptoms and response to alpha-blocker therapy. Urology 2006; 67: 1188-92 (Pubitemid 43818069)
99. Falahatkar S, Mokhtari G, Pourreza F, Asgari SA, Kamran AN,. Celecoxib for treatment of nocturia caused by benign prostatic hyperplasia: a prospective, randomized, double-blind, placebo-controlled study. Urology 2008; 72: 813-6
100. Johnson TM 2nd, Burrows PK, Kusek JW, et al. The effect of doxazosin, finasteride and combination therapy on nocturia in men with benign prostatic hyperplasia. J Urol 2007; 178: 2045-51 (Pubitemid 47538592)
101. Cai T, Gardener N, Abraham L, Boddi V, Abrams P, Bartoletti R,. Impact of surgical treatment on nocturia in men with benign prostatic obstruction. BJU Int 2006; 98: 799-805 (Pubitemid 44368028)
102. Margel D, Lifshitz D, Brown N, Lask D, Livne PM, Tal R,. Predictors of nocturia quality of life before and shortly after prostatectomy. Urology 2007; 70: 493-7 (Pubitemid 47464507)
103. Seki N, Yuki K, Takei M, Yamaguchi A, Naito S,. Analysis of the prognostic factors for overactive bladder symptoms following surgical treatment in patients with benign prostatic obstruction. Neurourol Urodyn 2009; 28: 197-201
104. Neal DE,. The National Prostatectomy Audit. Br J Urol 1997; 79 (Suppl. 2): 69-75 (Pubitemid 28321216)
105. Thomas AW, Cannon A, Bartlett E, Ellis-Jones J, Abrams P,. The natural history of lower urinary tract dysfunction in men: minimum 10-year urodynamic followup of transurethral resection of prostate for bladder outlet obstruction. J Urol 2005; 174: 1887-91 (Pubitemid 41546971)
106. Takami N, Okada A,. Triazolam and nitrazepam use in elderly outpatients. Ann Pharmacother 1993; 27: 506-9 (Pubitemid 23123905)
107. Kaye M,. Nocturia: a blinded, randomized, parallel placebo-controlled self-study of the effect of 5 different sedatives and analgesics. Can Urol Assoc J 2008; 2: 604-8
108. Song YS, Ku JH,. Zolpidem pharmacotherapy combined with alpha-blocker therapy for nocturia unresponsive to alpha-blocker monotherapy in men with lower urinary tract symptoms: a preliminary study. Int Urol Nephrol 2007; 39: 1147-52 (Pubitemid 350193608)